ASK REDCHAT ANYTHING ABOUT ALAUNOS THERAPEUTICS INC.
Alaunos Therapeutics Inc. (NASDAQ: TCRT)
Listen to this Section
$2.60
-0.0250
(
-0.95% )
9.1K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| TCR-T targeting neoantigensDetailsCancer, Solid tumor/s |
Failed |
| Ad-RTS-hIL-12 + veledimex (Controlled IL-12)DetailsGlioblastoma, Cancer |
Failed |
Market Data
|
| Open |
$2.60 |
| Previous Close |
$2.62 |
| Volume |
9.1K |
| Market Cap |
$6.40M |
| Day Range |
$2.41 - $2.63 |
| 52 Week Range |
$1.67 - $6.20 |
| Shares Outstanding |
2.44M |
| Change % |
-0.95% |
| Net Change |
▼ -0.0250 |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Pharmaceuticals and Biotechnology |
| IPO Year | 2005 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-833,756.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2025-06-26 |
Buy |
250.00 |
Vieser Jaime |
| 2025-06-26 |
Buy |
20804.00 |
Postma Robert W |
| 2025-04-15 |
Buy |
20804.00 |
Postma Robert W |
| 2024-06-10 |
Sale |
-19200.00 |
Weis Holger |
| 2024-06-10 |
Sale |
-12800.00 |
Vieser Jaime |
| 2024-06-10 |
Sale |
-12800.00 |
Postma Robert W |
| 2024-06-10 |
Sale |
-12800.00 |
Hofmeister Robert |
| 2024-01-23 |
Sale |
-600000.00 |
Hogue Dale Curtis Jr. |
| 2024-01-03 |
Sale |
-150000.00 |
Hogue Dale Curtis Jr. |
| 2023-09-05 |
Sale |
-68014.00 |
Boyle Kevin S. Sr. |